Telmisartan Market To Witness Growth Owing To Increasing Prevalence Of Hypertension
The Telmisartan Market is estimated to be valued at US$ 3567.30 Mn in 2023 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Telmisartan is an angiotensin II receptor antagonist used alone or in combination with hydrochlorothiazide for the treatment of hypertension or high blood pressure. It helps lower blood pressure by blocking the effects of angiotensin II, a chemical that narrows blood vessels. Telmisartan is available in the form of oral tablet and comes under the category of antihypertensive drugs.
Market Dynamics:
The telmisartan market is expected to witness significant growth over the forecast period owing to increasing prevalence of hypertension across the globe. According to the World Health Organization (WHO), hypertension was found in over 1.28 billion adults worldwide between 2015 and 2019, with the number expected to increase to over 1.56 billion by 2025. Furthermore, rising awareness regarding the benefits of telmisartan in managing blood pressure and improving cardiovascular outcomes is also expected to fuel the market growth. Some other key factors such as availability of generic versions and easy availability of OTC telmisartan formulations are anticipated to boost the market growth during the forecast period.
For more insights, read- http://insightfulmarket.weebly.com/blog/telemedicine-is-fastest-growing-segment-fueling-growth-of-the-global-telmisartan-market
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian